Generation and characterization of tissue-type plasminogen activator transgenic rats.

about

Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor.

P2860

Q55333995-2F694C9F-1CFF-4B64-800C-84B613AAC71A

P2860

Generation and characterization of tissue-type plasminogen activator transgenic rats.

Item

http://www.wikidata.org/entity/Q46255586

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Generation and characterization of tissue-type plasminogen activator transgenic rats.

@en

Generation and characterization of tissue-type plasminogen activator transgenic rats.

@nl

type

Item

label

Generation and characterization of tissue-type plasminogen activator transgenic rats.

@en

Generation and characterization of tissue-type plasminogen activator transgenic rats.

@nl

prefLabel

Generation and characterization of tissue-type plasminogen activator transgenic rats.

@en

Generation and characterization of tissue-type plasminogen activator transgenic rats.

@nl

P1476

Generation and characterization of tissue-type plasminogen activator transgenic rats.

@en

P2093

Kengo Noguchi

http://www.w3.org/2001/XMLSchema#string

Kyoji Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki Morishima

http://www.w3.org/2001/XMLSchema#string

Yusuke Ito

http://www.w3.org/2001/XMLSchema#string

P2860

Adaptation of the Folts and electrolytic methods of arterial thrombosis for the study of anti-thrombotic molecules in small animals

Reversible middle cerebral artery occlusion without craniectomy in rats

Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression

A gene expression atlas of the central nervous system based on bacterial artificial chromosomes

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.

Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding.

Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice.

Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis

Preparation and purification of microplasmin.

P2888

s11239-017-1582-1

P31

scholarly article

P356

10.1007/S11239-017-1582-1

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29168147

http://www.w3.org/2001/XMLSchema#string

P932

5756269

http://www.w3.org/2001/XMLSchema#string

Generation and characterization of tissue-type plasminogen activator transgenic rats.

about

P2860

P2860

Generation and characterization of tissue-type plasminogen activator transgenic rats.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698

P932